METHOD FOR TREATMENT OF LUNG DISEASES BY INHALATION ADMINISTRATION OF MESENCHYMAL STROMAL CELLS AND HEXAPEPTIDE Russian patent published in 2022 - IPC A61K9/72 A61K35/28 A61K38/08 A61P11/00 

FIELD: medicine.

SUBSTANCE: invention relates to the field of medicine, namely pulmonology, and is intended for the treatment of lung disease associated with elevated levels of interleukin-6. The method for treating this lung disease involves the inhalation of therapeutically effective amounts of mammalian mesenchymal stromal cells and therapeutically effective amounts of hexapeptide formula H-Tyr-D-Ala-Gly-Phe-Leu-Arg-OH (I) or its pharmacologically acceptable salt into a mammal in need. These cells and hexapeptide (I) are administered separately sequentially for one day or mixed immediately before administration and administered simultaneously. The use of the invention provides a

EFFECT: reduced levels of IL-6, a key pathogenetic factor determining the severity of the disease in lung disease.

3 cl, 4 tbl, 2 ex